A Friday ruling by a federal judge threw into uncertainty the decadeslong government approval of a key abortion drug.

This means the drug, mifepristone, could soon no longer be available to people seeking abortion care in the United States. Health care providers could be barred from prescribing the drug, even in states were abortion is legal.

The ruling will take seven days to go into effect, giving the federal government time to appeal. This means that, for now, mifepristone remains available.

(Additionally another, competing court ruling protects the status of mifepristone in some states, setting up a likely Supreme Court battle.)

For people seeking abortions, below are options to consider if mifepristone is soon no longer available.

THE RULINGS:Dueling federal rulings plunge future of abortion pill into legal uncertainty

PREVIOUS REPORTNG:A Texas judge could soon force a major abortion pill off market nationwide

In-clinic, procedural abortion care

In-clinic, or procedural, abortion care would not be affected by the ruling. However, abortion access advocates have expressed concerns over how the availability of clinic appointments would be affected.

Ashley Brink, clinic director at the abortion clinic Trust Women Kansas in Wichita, said her clinic has already been overwhelmed by a surge in out-of-state patients since the Supreme Court’s overturn last year of the historic Roe v. Wade ruling that protected abortion rights. Now, she worries the long lines and delays will only worsen if mifepristone is eventually pulled from the market.

People seeking abortion care can find providers in their area online through the Abortion Care Network, the National Abortion Federation or Planned Parenthood.